19. the Impact of Investigational Purified Microbiome Therapeutic SER-109 on Health-Related Quality of Life (hrqol) of Patients with Recurrent Clostridioides Difficile Infection (rcdi) in ECOSPOR III, a Placebo-Controlled Clinical Trial
Open forum infectious diseases（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要